Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 16, 2016
Total Value: $287M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MIRATI THERAPEUTICS INC. | 1,404,055 | $30.05M | 10.5% | $30.82 | — | Common | 60468T105 |
| FOLD | AMICUS THERAPEUTICS INC | 3,424,104 | $28.93M | 10.1% | $7.88 | -10.1% | Common | 03152W109 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 277,272 | $22.87M | 8.0% | $81.36 | 0.0% | Common | 09061G101 |
| SRPT | SAREPTA THERAPEUTICS -INC | 1,155,000 | $22.55M | 7.9% | $24.59 | -29.0% | Common | 803607100 |
| GILD | GILEAD SCIENCES INC | 175,400 | $16.11M | 5.6% | $63.47 | 0.0% | Common | 375558103 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 405,320 | $16.03M | 5.6% | $43.17 | -8.1% | Common | 64125C109 |
| — | LION BIOTECHNOLOGIES INC | 3,125,198 | $15.88M | 5.5% | $10.88 | — | Common | 53619R102 |
| — | CELATOR PHARMACEUTICALS INC. | 1,416,257 | $15.62M | 5.4% | $11.03 | — | Common | 15089R102 |
| — | MEDIVATION INC | 270,665 | $12.45M | 4.3% | $45.98 | — | Common | 58501N101 |
| BMY | BRISTOL MYERS SQUIBB CO. | 175,000 | $11.18M | 3.9% | $44.80 | 0.0% | Common | 110122108 |
| — | AGENUS - INC | 2,400,868 | $9.988M | 3.5% | $4.28 | — | Common | 00847G705 |
| — | ANACOR PHARMACEUTICALS INC | 166,700 | $8.91M | 3.1% | $53.45 | — | Common | 032420101 |
| — | NEURODERM LTD. | 537,477 | $7.589M | 2.6% | $18.73 | — | Common | M74231107 |
| VNDA | VANDA PHARMACEUTICALS INC | 854,579 | $7.144M | 2.5% | $11.25 | -27.1% | Common | 921659108 |
| — | TESARO INC. | 150,000 | $6.605M | 2.3% | $44.03 | — | Common | 881569107 |
| SRNE | SORRENTO THERAPEUTICS INC | 1,145,779 | $6.164M | 2.2% | $8.90 | -34.7% | Common | 83587F202 |
| — | ONCOTHYREON INC | 4,069,072 | $5.168M | 1.8% | $2.20 | — | Common | 682324108 |
| — | TELIGENT INC. | 925,000 | $4.533M | 1.6% | $8.90 | — | Common | 87960W104 |
| — | LA JOLLA PHARMACEUTICAL CO. | 211,672 | $4.426M | 1.5% | $21.78 | — | Common | 503459604 |
| — | FORTRESS BIOTECH INC. | 1,337,869 | $4.147M | 1.4% | $3.14 | — | Common | 34960Q109 |
| — | PERNIX THERAPEUTICS HOLDINGS | 3,889,900 | $4.084M | 1.4% | $4.51 | — | Common | 71426V108 |
| VCYT | VERACYTE INC | 730,514 | $3.945M | 1.4% | $9.84 | -39.9% | Common | 92337F107 |
| — | DERMIRA INC | 175,000 | $3.619M | 1.3% | $23.34 | — | Common | 24983L104 |
| — | GLOBAL BLOOD THERAPEEUTICS INC | 208,086 | $3.3M | 1.2% | $15.86 | — | Common | 37890U108 |
| — | IMMUNOMEDICS INC | 1,050,457 | $2.626M | 0.9% | $2.50 | — | Common | 452907108 |
| — | TRILLIUM THERAPEUTICS INC | 228,697 | $2.115M | 0.7% | $15.72 | — | Common | 89620X506 |
| SRPT | SAREPTA THERAPEUTICS -INC | 307,500 | $2.006M | 0.7% | $24.59 | -29.0% | Call | 803607100 |
| VCEL | VERICEL CORP. | 275,000 | $1.612M | 0.6% | $2.88 | -2.6% | Common | 92346J108 |
| — | NANTKWEST- INC | 194,912 | $1.602M | 0.6% | $10.02 | — | Common | 63016Q102 |
| — | EGALET CORPORATION. | 233,334 | $1.601M | 0.6% | $13.18 | — | Common | 28226B104 |
| — | AEGERION PHARMACEUTICALS INC | 306,800 | $1.135M | 0.4% | $13.60 | — | Common | 00767E102 |
| CRVS | CORVUS PHARMACEUTICALS INC | 74,800 | $1.085M | 0.4% | $14.35 | 0.0% | Common | 221015100 |
| CLLS | CELLECTIS - ADR | 25,000 | $688K | 0.2% | $33.40 | — | Sponsored ADS | 15117K103 |
| — | SPDR SERIES TRUST - S&P BIOTECH | 750,000 | $670K | 0.2% | — | — | Put | 78464A950 |
| — | CATALYST BIOSCIENCES INC. | 71,500 | $120K | 0.0% | $4.66 | — | Common | 14888D109 |
| — | INTREXON CORP. | 200,000 | $60,000 | 0.0% | — | — | Call | 46122T102 |
| — | ISHARES RUSSELL 2000 ETF | 250,000 | $51,000 | 0.0% | — | — | Put | 464287955 |